Barclays Upgrades Amgen (AMGN) to Equalweight
Barclays analyst Carter Gould upgraded Amgen (NASDAQ: AMGN) from Underweight ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
